The NHS is starting the world’s first vaccine programme to prevent gonorrhoea, using the 4CMenB meningitis vaccine in high‑risk groups from August 2025.
The WHO licensing agreement with the Medicines Patent Pool (MPP) and US National Institutes of Health (NIH) should improve access to some COVID health technologies, like early-stage vaccines and diagnostic tools.
By analysing patient samples, researchers believe they now understand how the human immune system protects the body from malaria - opening the door to new malaria treatments.
The World Health Organisation (WHO) say that the XE COVID variant (a mixture of two strains of Omicron) could be 10% more transmissible than Omicron itself.
Understanding the infection strategy of mosquito-borne viruses known as flaviviruses is key in the future development of treatments and possible vaccines
Researchers find the best protection against COVID-19 is vaccinations rather than natural immunity, when analysing how infection with SARS-CoV-2 affects the immune system.